POLITICS

US Senate panel sets hearing for Trump's FDA pick

PUBLISHED Sep 19, 2026, 3:40 PM ET

Read, Watch or Listen

US Senate panel sets hearing for Trump's FDA pick

Media Bias Meter

Sources: 5

Center 60%

Right 40%

Sources: 5

The United States Senate Health, Education, Labor, and Pensions Committee scheduled a confirmation hearing for Dr. Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration. Set for September 24, the hearing addresses leadership stability at the agency following the departure of former commissioner Marty Makary in May. Overton, currently a White House policy aide and former researcher at the America First Policy Institute, enters nomination amid severe staffing shortages, with over three thousand employees departing over the past year. Her nomination coincides with administration policy initiatives regarding the national childhood vaccination schedule and reproductive health medications. If confirmed, Overton will face intense congressional scrutiny regarding regulatory independence, drug approvals, and rebuilding institutional morale. The FDA remains responsible for regulating all domestic drugs, biological products, and medical treatments, making leadership continuity critical for public health administration and pharmaceutical industry oversight across the United States.

By Haya | JQJO News

Timeline of Events

On August 19, 2026 President Donald Trump officially nominated Dr. Heidi Overton to lead FDA.
On May 1, 2026 Former FDA commissioner Marty Makary resigned after thirteen months in office.
On September 17, 2026 The Senate health committee announced a confirmation hearing for September 24.
On September 24, 2026 The Senate committee will conduct confirmation hearings for the FDA nominee.

News Intelligence

Immediate US impact: Immediate US impact involves Senate confirmation hearings shaping federal health leadership.
Possible long-term US impact: Long term US impact alters federal regulatory oversight on vaccines and drugs.
Most affected groups: Most affected groups include pharmaceutical companies, public health officials, and medical researchers.
Reader priority: Reader priority requires tracking committee testimony, witness statements, and legislative votes.

Media Bias

Articles Published:: 5
Right Leaning:: 2
Left Leaning:: 0
Neutral:: 3

Explain Framing

Left: Emphasizes administration controversies and potential public health policy risks. Center: Reports factual schedule details regarding the upcoming Senate confirmation hearing. Right: Highlights conservative credentials and America First alignment for reforms.